Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2019 June;110(3) > Minerva Medica 2019 June;110(3):264-7

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Minerva Medica 2019 June;110(3):264-7

DOI: 10.23736/S0026-4806.18.05854-8

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Bioavailability of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg single dose vs. single components

Roberto IMBERTI 1 ✉, Simona DE GREGORI 2, Leonardo RABAGLIA 3, Mario REGAZZI 4

1 Phase I Clinical Trial and Experimental Therapy Unit, IRCCS Policlinic San Matteo Foundation, Pavia, Italy; 2 Unit of Clinical and Experimental Pharmacokinetics, IRCCS Policlinic San Matteo Foundation, Pavia, Italy; 3 Mediolanum farmaceutici S.p.A., Milan, Italy; 4 Società Italiana di Farmacocinetica e Biofarmaceutica (S.I.F.E.B.), Pavia, Italy


HTML PDF


top of page

 

Copyright © 2022 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions